Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease cardiomyopathy
Phenotype C0013264|duchenne muscular dystrophy
Sentences 14
PubMedID- 26058601 cardiomyopathy in duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers.
PubMedID- 21768542 Background: nearly universal cardiomyopathy in duchenne muscular dystrophy (dmd) contributes to heart failure and death.
PubMedID- 22655514 No consensus exists regarding the proper pharmacologic intervention and timing of treatment for cardiomyopathy in patients with duchenne muscular dystrophy.
PubMedID- 22266080 The functional changes observed are comparable to the evolution of dilated cardiomyopathy in duchenne muscular dystrophy, indicating that mdx/utrn(-/-) dystrophin/utrophin-deficient mice are a possible phenotypic model for cardiomyopathy in duchenne muscular dystrophy.
PubMedID- 24969422 These findings provide new mechanistic and functional insight into cardiomyopathy associated with duchenne muscular dystrophy.
PubMedID- 21784508 This complication was judged most likely to be part of the well described pattern of cardiomyopathy associated with duchenne muscular dystrophy.
PubMedID- 19943106 cardiomyopathy in duchenne muscular dystrophy: pathogenesis and therapeutics.
PubMedID- 21575230 Background: cardiomyopathy in duchenne muscular dystrophy (dmd) is an increasing cause of death in patients.
PubMedID- 25554404 Eplerenone for early cardiomyopathy in duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
PubMedID- 23400933 A dilated cardiomyopathy (dcm) is associated with duchenne muscular dystrophy (dmd).
PubMedID- 25554403 Prevention of cardiomyopathy in duchenne muscular dystrophy.
PubMedID- 23866715 Oral corticosteroids and onset of cardiomyopathy in duchenne muscular dystrophy.
PubMedID- 22318092 Dystrophin-deficient duchenne cardiomyopathy is associated with duchenne muscular dystrophy (dmd), the most common lethal muscular dystrophy.
PubMedID- 23352781 Objectives: this study sought to determine the impact of steroid therapy on cardiomyopathy and mortality in patients with duchenne muscular dystrophy (dmd).

Page: 1